Natera
Healthcare & Life Sci
Company overview
Natera runs non-invasive genetic tests built on cell-free DNA technology, with products for women's health, cancer, and organ health. Its main tests are Panorama for prenatal testing, Horizon for carrier screening, Signatera for cancer monitoring, and Prospera for transplant assessment.
Matthew Rabinowitz and Jonathan Sheena founded the company in 2004. It trades on Nasdaq under the ticker NTRA. By May 2021 it had run over 3 million cell-free DNA tests, and as of 2022 it had 3,018 employees and $797 million in revenue. Natera is a top-tier H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- San Jose, United States